Veterinary nutraceutical medicine

Canadian Veterinary Journal

Volumn 41, Issue 3, 2000, Pages 231-233

  Taillon, Craig ^a   Andreasen, Alan ^a  

^a Fortius Natural Nutrition   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; OMEGA 3 FATTY ACID;

ALTERNATIVE MEDICINE; CANADA; CLINICAL PRACTICE; COLOSTRUM; DATA BASE; NONHUMAN; NOTE; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; COMPLEMENTARY THERAPIES; MICRONUTRIENTS; NUTRITIONAL REQUIREMENTS; PHARMACEUTICAL PREPARATIONS; VETERINARY MEDICINE;

EID: 0034032838     PISSN: 00085286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Veterinary Medical Association. Guidelines for alternative and complementary veterinary medicine. In: 1999 AVMA Directory and Resource Manual, 48th ed. Schaumburg, Illinois: American Veterinary Medical Association.
2. Anderson BC. Members oppose AVMA's guidelines for alternative and complementary veterinary medicine. J Am Vet Med Assoc 1996;209:1687.
3. Kitemiller G. Consumer research: Supplements - attitudes and behaviors of dietary supplement users In: Nutracon '99 Proceedings. Book 4. Stanford, Connecticut: Global Business Research, 1999.
4. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Medica 1991;57:1-7.
5. Sharma OP. Antioxidant properties of curcumin and related compounds. Biochem Pharmacol 1976;25:1811-1825.
6. Toda S, Miyase T, Arich H. Natural antioxidants: Antioxidative compounds isolated from rhizome of Curcuma longa L. Chem Pharmacol Bull 1985;33:1725-1728.
7. Srimal R, Shawan B. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973;25:447-452.
8. Shankar TNB, Shantha NV, Ramesh HP. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs & monkeys. Indian J Exp Biol 1980;18:73-75.
9. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Nat Acad Sci 1983;80:3581-3584.
10. von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985;76:2446-2450.
11. Tizard IR. Veterinary Immunology: An Introduction, 5th ed. Toronto: W B Saunders, 1996.
12. Francis GL, Read LC, Ballard J, et al. Purification and partial sequence analysis of insulin-like growth factor-I from bovine colostrum. Biochem J 1986;233:207-213.
13. Anderson BF, Baker HM, Norris GE, Rice DW, Baker EN. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8-Å resolution. J Mol Biol 1989;209: 711-734.
14. Sasaki M, Davis CL, Larson BL. Production and turnover of IgG1 and IgG2 immunoglobulins in the bovine around parturition. J Dairy Sci 1976;59:2046-2055.
15. Tyler JW, Steevens BJ, Hostetler DE, Holle JM, Denbigh JL Jr. Colostral immunoglobulin concentration in Holstein and Guernsey cows. Am J Vet Res 1999;60:1136-1139.
16. Oyenyi OO, Hunte AG. Colostral constituents including immunoglobulins in the first three milkings postpartum. J Dairy Sci 1978;61:44-48.
17. Bitzan MM, Gold BD, Philpott DJ, et al. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J Infect Dis 1998;177:955-961.
18. Pakdaman R, Petitjean M, El Hage Chahaine J-M. Transferrins: A mechanism for iron uptake by lactoferrin. Eur J Biochem 1998;254:144-153.
19. Dionysius DA, Milne JM. Antibacterial peptides of bovine lactoferrin: Purification and characterization. J Dairy Sci 1997;80: 667-674.
20. Miyauchi H, Hashimoto S, Nakajima M, Shinoda I. Fukuwatari Y, Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: Identification of its active domain. Cell Immunol 1998;187:34-37.
21. Miyauchi H, Kaino A, Shinoda I. Fukuwatari Y. Hayasawa H. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer's patch cells. J Dairy Sci 1997;80:2330-2339.
22. Swart PJ, Kuipers EM, Smit C, van der Strate BW, Harmsen MC, Meijer DK. Lactoferrin: Antiviral activity of lactoferrin. Adv Exp Med Biol 1998;443:205-213.
23. Sato R, Inanami O, Tanaka Y, Takase M, Naito Y. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. Am J Vet Res 1996;57:1443-1446.
24. Watkins LR, Maier SF, Goehler LE. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995;63:289-302.
25. Wilson GB, Paddock GV, Fudenberg HH. Bovine 'transfer factor': An oligoribonucleopeptide that initiates antigen-specific lymphocyte responsiveness. Thymus 1982;4:335-350.
26. Kirkpatrick CH. Activities and characteristics of transfer factors. Biotherapy 1996;9:13-16.
27. Radesevich JK, Scott GH, Olson GB. Delayed-type hypersensitivity responses induced by bovine colostral components. Am J Vet Res 1985;46:875-878.
28. Oda S, Satoh H, Sugawara T, et al. Insulin-like growth factor-I, GH, insulin and glucagon concentrations in bovine colostrum and in plasma of dairy cows and neonatal calves around parturition. Comp Biochem Physiol 1989;94A:805-808.
29. Ginjala V, Pakkanen R. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor (IGF-1) in bovine colostrum samples. J Immunoassay 1998;19:195-207.
30. Ballard FJ, Nield MK, Francis GW, Dahlenburg GW, Wallace JC. The relationship between the insulin content and inhibitory effects of bovine colostrum on protein breakdown in cultured cells. J Cell Physiol 1982;110:249-254.
31. Montaner B, Asbert M, Perez-Tomas R. Immunolocalization of transforming growth factor-α and epidermal growth factor receptor in the rat gastroduodenal area. Dig Dis Sci 1999;44: 1408-1416.
32. Hardin JA, Buret A, Meddings JB, Gall DG. Effect of epidermal growth factor on enterocyte brush-border surface area. Am J Physiol 1993;264:G312-318.
33. Alexander AN, Carey HV. Oral IGF-I enhances nutrient and electrolyte absorption in neonatal piglet intestine. Am J Physiol 1999;277:G619-G625.
34. Opleta-Madsen K, Hardin J, Gall DG. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport. Am J Physiol 1991;260:G807-G814.
35. Bridger JC, Brown JF. Development of immunity to porcine rotavirus in piglets protected from disease by bovine colostrum. Infect Immun 1981;31:906-910.
36. Jenkins MC, O'Brien C, Trout J, Guidry A, Fayer R. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Vaccine 1999;17:2453-2460.
37. Crabb JH. Antibody-based immunotherapy of cryptosporidiosis. Adv Parasitol 1998;40:121-149.
38. Leitch EC, Willcox MDP. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 1999;48: 867-871.